{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:16:16Z","timestamp":1790842576091,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.parkreldis.2022.05.024","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T12:33:55Z","timestamp":1654259635000},"page":"24-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-7649","authenticated-orcid":false,"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2022.05.024_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","article-title":"Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?","volume":"16","author":"Jellinger","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"64 Suppl","key":"10.1016\/j.parkreldis.2022.05.024_bib3","first-page":"S81","article-title":"Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis","volume":"2","author":"Goetz","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib4","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/gps.1738","article-title":"Patients with Lewy body dementia use more resources than those with Alzheimer's disease","volume":"22","author":"Bostr\u00f6m","year":"2007","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib6","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib7","first-page":"905","article-title":"Neuropathologic aspects of co-occurrence of dementia with Lewy bodies and Alzheimer's disease [Japanese]","volume":"70","author":"Takao","year":"2018","journal-title":"Brain Nerve"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0074-7742(09)00411-5","article-title":"Lewy body dementia","volume":"84","author":"Hanson","year":"2009","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jalz.2016.04.002","article-title":"Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011-2013","volume":"13","author":"Goodman","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib10","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1016\/j.jacc.2019.04.034","article-title":"Vascular cognitive impairment and dementia: JACC scientific expert panel","volume":"73","author":"Iadecola","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib11","article-title":"Lewy body dementia","author":"Haider","year":"2022","journal-title":"In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-."},{"issue":"43 Suppl","key":"10.1016\/j.parkreldis.2022.05.024_bib12","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1017\/cjn.2016.2","article-title":"The prevalence and incidence of dementia with Lewy bodies: a systematic review","volume":"1","author":"Hogan","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ageing\/afi190","article-title":"A systematic review of prevalence and incidence studies of dementia with Lewy bodies,","volume":"34","author":"Zaccai","year":"2005","journal-title":"Age Ageing"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib14","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jnnp-2017-316844","article-title":"Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis","volume":"89","author":"Rizzo","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3233\/JAD-170274","article-title":"Accuracy of clinical diagnosis of dementia with Lewy bodies versus neuropathology","volume":"59","author":"Skogseth","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib17","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mds.10455","article-title":"Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study,","volume":"18","author":"Burn","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gaitpost.2016.08.009","article-title":"Motor performance differentiates individuals with Lewy body dementia, Parkinson's and Alzheimer's disease","volume":"50","author":"Fritz","year":"2016","journal-title":"Gait Posture"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000375363","article-title":"Clinical and neuropsychological differences between mild Parkinson's disease dementia and dementia with Lewy bodies","volume":"5","author":"Petrova","year":"2015","journal-title":"Dement Geriatr. Cogn. Dis. Extra."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1212\/WNL.0b013e31822c9148","article-title":"Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies","volume":"77","author":"Ferman","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","article-title":"Dementia with Lewy bodies: an update and outlook","volume":"14","author":"Outeiro","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib23","doi-asserted-by":"crossref","first-page":"e2076","DOI":"10.1212\/WNL.0000000000009434","article-title":"Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies","volume":"94","author":"Smirnov","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib24","doi-asserted-by":"crossref","first-page":"748096","DOI":"10.3389\/fneur.2021.748096","volume":"12","author":"Chang","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years,","volume":"23","author":"Hely","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib26","doi-asserted-by":"crossref","first-page":"e1855","DOI":"10.1212\/WNL.0000000000011699","article-title":"Cognitive profile and markers of AD-type pathology in patients with Lewy body dementias","volume":"96","author":"Howard","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","article-title":"Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies","volume":"88","author":"Lemstra","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamapsychiatry.2021.4363","article-title":"Associations between neuropsychiatric symptoms and neuropathological diagnoses of Alzheimer disease and related dementias","volume":"79","author":"Devanand","year":"2022","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib29","series-title":"Dementia with Lewy Bodies and Parkinson's Disease-Dementia: Current Concepts and Controversies","first-page":"615","author":"Jellinger","year":"2018"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/nan.12554","article-title":"Review: clinical, neuropathological and genetic features of Lewy body dementias","volume":"45","author":"Hansen","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.parkreldis.2014.02.012","article-title":"Concomitant pathologies among a spectrum of parkinsonian disorders","volume":"20","author":"Dugger","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ana.23659","article-title":"Neuropathologic substrates of Parkinson disease dementia","volume":"72","author":"Irwin","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and molecular diagnosis of synucleinopathies","volume":"16","author":"Koga","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib34","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/NEN.0b013e3181d88e63","article-title":"Inverse relationship between cerebrovascular lesions and severity of Lewy body pathology in patients with Lewy body diseases","volume":"69","author":"Ghebremedhin","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/jnc.14698","article-title":"Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions","volume":"150","author":"Walker","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2010.09.036","article-title":"Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia","volume":"486","author":"Fujishiro","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib37","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","article-title":"Differences in neuropathologic characteristics across the Lewy body dementia spectrum","volume":"67","author":"Ballard","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib38","first-page":"1234","article-title":"Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies","volume":"90","author":"Smith","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.parkreldis.2005.09.001","article-title":"Pathological substrate of dementia in Parkinson's disease\u2013its relation to DLB and DLBD","volume":"12","author":"Jellinger","year":"2006","journal-title":"Park. Relat. Disord."},{"issue":"11 Suppl","key":"10.1016\/j.parkreldis.2022.05.024_bib40","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.parkreldis.2004.10.014","article-title":"Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?","volume":"1","author":"Tsuboi","year":"2005","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.brainresbull.2009.06.018","article-title":"Neuropathology of Lewy body disorders","volume":"80","author":"K\u00f6vari","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib42","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00401-006-0088-2","article-title":"Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies?","volume":"112","author":"Jellinger","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib43","series-title":"Striatal Beta-Amyloid in Dementia with Lewy Bodies but Not Parkinson's Disease","first-page":"713","author":"Halliday","year":"2011"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib44","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnen\/nlw070","article-title":"Distribution and load of amyloid-beta pathology in Parkinson disease and dementia with Lewy bodies","volume":"75","author":"Hepp","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib45","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3233\/JPD-191600","article-title":"Regional structural hippocampal differences between dementia with Lewy bodies and Parkinson's disease","volume":"9","author":"de Schipper","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib46","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/nan.12308","article-title":"Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum","volume":"42","author":"Sierra","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib47","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.parkreldis.2013.05.010","article-title":"Neuropathology of dementia in a large cohort of patients with Parkinson's disease","volume":"19","author":"Horvath","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mds.27867","article-title":"Pathological influences on clinical heterogeneity in Lewy body diseases","volume":"35","author":"Coughlin","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib49","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/ene.15211","article-title":"The influence of cerebrovascular disease in dementia with Lewy bodies and Parkinson's disease dementia,","volume":"29","author":"Hijazi","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/nan.12648","article-title":"Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia","volume":"47","author":"Hansen","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib51","series-title":"Cerebral Amyloid Angiopathy in Lewy Body Disease","first-page":"473","author":"Jellinger","year":"2008"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib52","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000285518","article-title":"Prevalence and impact of cerebrovascular lesions in Alzheimer and Lewy body diseases","volume":"7","author":"Jellinger","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","article-title":"Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease","volume":"115","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib54","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neurobiolaging.2021.04.029","article-title":"Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies","volume":"105","author":"Ferreira","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2017.12.018","article-title":"White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease","volume":"385","author":"Joki","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib56","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3233\/JAD-210669","article-title":"Implication of small vessel disease MRI markers in Alzheimer's disease and Lewy body disease","volume":"83","author":"Park","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib57","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.neurobiolaging.2011.10.026","article-title":"Microbleeds relate to altered amyloid-beta metabolism in Alzheimer's disease","volume":"33","author":"Goos","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib58","first-page":"101","article-title":"The impact of cerebral amyloid angiopathy in Lewy body dementia: a neuropathological study with magnetic resonance imaging correlations,","volume":"1","author":"De Reuck","year":"2018","journal-title":"J. Neurodeg Dis. Res."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib59","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/gps.5485","article-title":"Association of cerebral microbleeds with cerebrospinal fluid Alzheimer-biomarkers and clinical symptoms in early dementia with Lewy bodies","volume":"36","author":"Mendes","year":"2021","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib60","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","article-title":"Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons","volume":"85","author":"Boyle","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00401-003-0796-9","article-title":"Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology\u2013a pilot study","volume":"107","author":"Attems","year":"2004","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2990.2010.01137.x","article-title":"Review: sporadic cerebral amyloid angiopathy","volume":"37","author":"Attems","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib63","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jnen\/nlab131","article-title":"The frequency of cerebral amyloid angiopathy in primary age-related tauopathy,","volume":"81","author":"Walker","year":"2022","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib64","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jnen\/nlaa160","article-title":"Vascular lesions, APOE epsilon4, and tau pathology in Alzheimer disease","volume":"80","author":"Nichols","year":"2021","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib65","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3233\/JAD-191151","article-title":"Braak stage, cerebral amyloid angiopathy, and cognitive decline in early Alzheimer's disease","volume":"74","author":"Malek-Ahmadi","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib66","doi-asserted-by":"crossref","first-page":"7247325","DOI":"10.1155\/2019\/7247325","article-title":"The impact of cerebral amyloid angiopathy in various neurodegenerative dementia syndromes: a neuropathological study,","volume":"2019","author":"De Reuck","year":"2019","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib67","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00401-005-1064-y","article-title":"Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy","volume":"110","author":"Attems","year":"2005","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib68","article-title":"Morphological differences between dementia with Lewy bodies and Parkinson's disease-dementia. Letter to the Editor","volume":"48","author":"Jellinger","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib69","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00702-021-02345-9","article-title":"Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases","volume":"128","author":"Jellinger","year":"2021","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib71","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","article-title":"Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium","volume":"18","author":"Alafuzoff","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib72","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/jnen\/59.8.733","article-title":"Sequence of Abeta-protein deposition in the human medial temporal lobe","volume":"59","author":"Thal","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib73","first-page":"19","article-title":"Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue","volume":"3","author":"Love","year":"2014","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib74","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s004010050726","article-title":"Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia","volume":"94","author":"Bancher","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00002093-200101000-00005","article-title":"Clinical and pathologic features of two groups of patients with dementia with Lewy bodies: effect of coexisting Alzheimer-type lesion load","volume":"15","author":"Del Ser","year":"2001","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-7091-6846-2_7","article-title":"The Lewy body variant of Alzheimer disease,","volume":"51","author":"Hansen","year":"1997","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib77","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13195-018-0417-4","article-title":"Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional study","volume":"10","author":"Mouton","year":"2018","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib78","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/jamaneurol.2017.0603","article-title":"Survival and causes of death among people with clinically diagnosed synucleinopathies with parkinsonism: a population-based study","volume":"74","author":"Savica","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib79","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0404.2004.00292.x","article-title":"Mortality in Parkinson's disease and its association with dementia and depression","volume":"110","author":"Hughes","year":"2004","journal-title":"Acta Neurol. Scand."},{"issue":"256 Suppl","key":"10.1016\/j.parkreldis.2022.05.024_bib80","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00415-009-5243-y","article-title":"Formation and development of Lewy pathology: a critical update","volume":"3","author":"Jellinger","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib81","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1212\/WNL.0000000000007855","article-title":"Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease","volume":"93","author":"Shirvan","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib82","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1212\/WNL.42.11.2131","article-title":"Amyloid angiopathy in diffuse Lewy body disease","volume":"42","author":"Wu","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib83","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.nbd.2010.10.005","article-title":"Striatal A\u00df peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes","volume":"41","author":"Kalaitzakis","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib84","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/jnnp-2020-324606","article-title":"(123)I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease: a new quantitative analysis of autopsy confirmed cases","volume":"92","author":"Oliveira","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib85","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1093\/brain\/awab218","article-title":"Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks","volume":"144","author":"Schumacher","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib86","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1212\/WNL.0000000000009763","article-title":"Subtypes of dementia with Lewy bodies are associated with alpha-synuclein and tau distribution","volume":"95","author":"Ferman","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib87","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1212\/WNL.0000000000005166","article-title":"CSF tau and beta-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders","volume":"90","author":"Irwin","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib88","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jalz.2017.09.014","article-title":"The limbic and neocortical contribution of a-synuclein, tau, and amyloid \u00df to disease duration in dementia with Lewy bodies,","volume":"14","author":"Ferman","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib89","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.parkreldis.2020.09.030","article-title":"Prevalence and clinical associations of tau in Lewy body dementias: a systematic review and meta-analysis,","volume":"80","author":"Chin","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib90","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.jnen.0000205145.54457.ea","article-title":"Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies","volume":"65","author":"Deramecourt","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib91","article-title":"Association between amyloid-beta deposition and cortical thickness in dementia with Lewy bodies","volume":"24","author":"Chin","year":"2022","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib92","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000082349","article-title":"Correlation of entorhinal amyloid with memory in Alzheimer's and vascular but not Lewy body dementia","volume":"19","author":"Thomas","year":"2005","journal-title":"Dement. Geriatr. Cognit. Disord."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib93","first-page":"216","article-title":"Regional overlap of pathologies in Lewy body disorders","volume":"76","author":"Colom-Cadena","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib94","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13195-019-0473-4","article-title":"Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria","volume":"11","author":"Caminiti","year":"2019","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib95","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.109.065870","article-title":"The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies,","volume":"50","author":"Lim","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib96","doi-asserted-by":"crossref","first-page":"102504","DOI":"10.1016\/j.nicl.2020.102504","article-title":"Tau PET and relative cerebral blood flow in dementia with Lewy bodies: a PET study,","volume":"28","author":"Wolters","year":"2020","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib97","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","article-title":"Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture","volume":"53","author":"Chia","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib98","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2017.09.009","article-title":"Parkinson's disease susceptibility variants and severity of Lewy body pathology","volume":"44","author":"Heckman","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib99","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-009-0501-8","article-title":"Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies","volume":"118","author":"Revesz","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib100","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.12688\/f1000research.11725.1","article-title":"Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies","volume":"6","author":"Weil","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib101","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib102","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib103","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/brain\/awab099","article-title":"Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease","volume":"144","author":"Spina","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/2051-5960-1-65","article-title":"Clinical and multimodal biomarker correlates of ADNI neuropathological findings","volume":"1","author":"Toledo","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib105","doi-asserted-by":"crossref","first-page":"120015","DOI":"10.1016\/j.jns.2021.120015","article-title":"Parkinsonism and dementia","volume":"433","author":"Koros","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib106","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1073\/pnas.211412398","article-title":"Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease","volume":"98","author":"Masliah","year":"2001","journal-title":"Proc Natl. Acad. Sci. USA"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib107","doi-asserted-by":"crossref","first-page":"13149","DOI":"10.1038\/s41598-020-70174-z","article-title":"Differential protein expression in diverse brain areas of Parkinson's and Alzheimer's disease patients","volume":"10","author":"Esteves","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib108","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib109","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib110","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3233\/JAD-201548","article-title":"Significant overlap of alpha-synuclein, amyloid-beta, and phospho-tau pathologies in neuropathological diagnosis of Lewy-related pathology","volume":"80","author":"Cong","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib111","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct alpha-synuclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib112","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/acn3.51482","article-title":"Quantifying regional alpha-synuclein, amyloid beta, and tau accumulation in Lewy body dementia","volume":"9","author":"Miller","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib113","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1582-4934.2011.01507.x","article-title":"Interaction between pathogenic proteins in neurodegenerative disorders","volume":"16","author":"Jellinger","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib114","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","article-title":"Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes","volume":"129","author":"Walker","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2022.05.024_bib115","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","article-title":"Initiation and synergistic fibrillization of tau and alpha-synuclein","volume":"300","author":"Giasson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2022.05.024_bib116","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-007-0336-0","article-title":"Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients","volume":"115","author":"Lashley","year":"2008","journal-title":"Acta Neuropathol."}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022001791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022001791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:25:43Z","timestamp":1761179143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802022001791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":116,"alternative-id":["S1353802022001791"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.05.024","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}